Bert Spilker's Pharma Principles of The Week

Friday, March 2, 2007 07:46 AM

Posted by: Bert Spilker

  • For a difference to make a difference it must be a real difference.  Keep this in mind when deciding how much of a difference in safety, efficacy or convenience will be necessary to receive regulatory approval and encourage physicians to use your product.
  • FDA based slogans include: Incompetence on your part does not constitute malfeasance on ours.  Also, Failure to plan on your part does not constitute an emergency on ours.
  • It is artificial to describe inclusion and exclusion criteria as if they were two separate categories of criteria. The only difference between them is that one set of criteria is expressed in positive terms and the other in negative terms.

Bert Spilker, PhD, MD is an independent consultant who was most recently the Senior Vice President of Scientific and Regulatory Affairs for PhRMA. He is the founder of Bert Spilker & Associates (BS&A).

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs